Inhibidores peptídicos lipidados del receptor de interleucina-23

La presente invención se refiere a nuevos inhibidores peptídicos lipidados del receptor de interleucina-23 (IL-23R) o sales, solvatos y/u otras formas farmacéuticamente aceptables de los mismos, composiciones farmacéuticas correspondientes, métodos y/o usos de los inhibidores de IL-23R para tratamie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Santhosh NEELAMKAVIL, Stephanie, A. BARROS, Douglas RIEXINGER, Sandeep SOMANI, Martina LOLLOBRIGIDA, James DANIEL, Jing ZHANG, Chengzao SUN, Sonia DEL RIZZO, Roberto COSTANTE, Ashok BHANDARI, Charles HENDRICK, Elisabetta BIANCHI, Federica ROSOLIA, Raymond, J. PATCH, Tran Trung TRAN, Brian FREDERICK, Danila BRANCA
Format:	Patent
Sprache:	spa
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	La presente invención se refiere a nuevos inhibidores peptídicos lipidados del receptor de interleucina-23 (IL-23R) o sales, solvatos y/u otras formas farmacéuticamente aceptables de los mismos, composiciones farmacéuticas correspondientes, métodos y/o usos de los inhibidores de IL-23R para tratamiento de enfermedades inflamatorias autoinmunitarias y/o trastornos relacionados. The present invention relates to novel lipidated peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salts, solvates and/or other forms thereof., corresponding pharmaceutical compositions, methods and/or uses of the IL-23R inhibitors for treatment of autoimmune inflammation diseases and/or related disorders. The present invention relates to novel lipidated peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salts, solvates and/or other forms thereof, corresponding pharmaceutical compositions, methods and/or uses of the IL-23R inhibitors for treatment of autoimmune inflammation diseases and/or related disorders.